Trials / Unknown
UnknownNCT06055907
Influence of Vasopressors on Anti-Xa Activity in Critically Ill Patients
Anti-Xa Activity in Patients Receiving Different Vasopressors.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Medical University of Gdansk · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Critically ill patients require antithrombotic prophylaxis. At the same time, majority of them is receiving various vasopressors. The aim of the study is to determine whether there is a difference in anti-Xa activity, which is a marker of anti thrombotic activity of low molecular weight heparins, between the patients receiving norepinephrine with argipressin, compared to those receiving norepinephrine alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Serum anti-Xa activity | 4 hours after third dose of dalteparin, serum anti-Xa activity is measured |
Timeline
- Start date
- 2023-05-15
- Primary completion
- 2024-09-01
- Completion
- 2024-09-01
- First posted
- 2023-09-28
- Last updated
- 2023-09-28
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT06055907. Inclusion in this directory is not an endorsement.